Uriel Abdallah Sánchez-Pacheco

Uriel Abdallah Sánchez-Pacheco

Auto-generated profile, based on publicly available information

Uriel Abdallah Sánchez-Pacheco

Laboratory of Pharmaceutical Biotechnology, Faculty of Pharmacy, Autonomous University of the State of Morelos, Cuernavaca, Morelos, Mexico

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2025 in BioMed Research International
Verified
Journal Article
Open access
CSConcepción Sosa-García
Concepción Sosa-García
USUriel Abdallah Sánchez-Pacheco
Uriel Abdallah Sánchez-Pacheco
CMCarlos Alberto Montalvan Tavira Montalvan
Carlos Alberto Montalvan Tavira Montalvan
Angélica Meneses AcostaAngélica Meneses Acosta
Angélica Meneses Acosta
Recombinant proteins represent one of the greatest achievements of modern pharmaceutical biotechnology, as they are increasingly used across nearly all branches of medicine to treat a wide range of conditions. In response to this demand, various cell engineering approaches have been developed to improve their expression. Some of these approaches involve the use of genetic elements that prevent the silencing of the gene of interest, as well as the generation of resistant cell lines to inhibit or avoid programmed cell death (PCD). This research focuses on analyzing the effects of overexpression of UCOE elements and the HSP27 protein, both individually and together, on the production of human rIFN γ in HEK293 cells. Our results show that 4‐Kb UCOE elements have no effect on protein production in HEK293 cells, while overexpression of HSP27 prolongs the stationary phase during growth kinetics. The Qp of rIFN γ is 96‐fold higher in clones containing the HSP27/UCOE combination compared to the clone containing only UCOE elements or to the control HEK293 cells. These results correlate with the MCP analyses, which showed that overexpression of HSP27 decreased the expression of Bax, caspase 3, cytochrome C, Beclin, and LC3II mRNA. Finally, this study suggests the potential utility of a cell engineering approach based on the overexpression of the human HSP27 protein for enhancing the production of recombinant viruses and proteins in HEK293 cells.